Overview

Study To Assess The Reproducibility And Sensitivity Of Quantitative Sensory Testing In Patients With Neuropathic Pain

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
Conventional pain efficacy measures such as Visual Analogue Scores (VAS) are often unable to detect treatment efficacy in small-scale clinical trials. Combining conventional pain efficacy measures with quantitative sensory testing (QST) may provide more sensitive and informative outcome measures in clinical trials.
Phase:
N/A
Details
Lead Sponsor:
Pfizer
Treatments:
Pregabalin